Status:
COMPLETED
Gram Negative Bacteremia, Risk Factors for Failure of Therapy
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
PI discretionary funding
Conditions:
Gram-Negative Bacterial Infections
Eligibility:
All Genders
18+ years
Brief Summary
The aims of this study are to: * Determine the risk factors for multidrug resistance in bloodstream isolates of Gram negative bacilli * Determine the mechanisms of multidrug resistance in bloodstream...
Detailed Description
The following variables will be followed: time and location of positive cultures, underlying diseases and severity of illness, recent immunomodulative therapies, physical exam findings, laboratory and...
Eligibility Criteria
Inclusion
- All patients at the aforementioned institutions that have Gram negative bacteremia will be included in the study.
- Women with childbearing potential will also be included in this study. Since this is an observational study, no added risk is conferred to the woman or potential progeny. HIV serostatus will not be specifically investigated for participation in this study.
Exclusion
- None
Key Trial Info
Start Date :
April 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2016
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00177957
Start Date
April 1 2005
End Date
May 1 2016
Last Update
June 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213